RCM-1
RCM-1 is a forkhead box M1 (FOXM1) inhibitor with an EC50 of 0.72 μM in U2OS cells. RCM-1 blocks the nuclear localization and increased the proteasomal degradation of FOXM1. RCM-1 can be used for asthma and other chronic airway diseases research[1].
Product Specifications
CAS Number
339163-65-4
UNSPSC
12352005
Hazard Statement
H315, H319
Target
DNA/RNA Synthesis
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/RCM-1.html
Purity
98.56
Solubility
DMSO : 16.67 mg/mL (ultrasonic)
Smiles
N#CC1=C(C2=CC=CS2)C=C(C3=CC=CS3)N=C1SCC(C4=CC=CS4)=O
Molecular Formula
C20H12N2OS4
Molecular Weight
424.58
Precautions
H315, H319
References & Citations
[1]Lifeng Sun, et al. The FOXM1 inhibitor RCM-1 suppresses goblet cell metaplasia and prevents IL-13 and STAT6 signaling in allergen-exposed mice. Sci Signal. 2017 Apr 18;10 (475) :eaai8583.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC403295-500 1x 500 µL
Sarcomeric Actinin Alpha 2 / ACTN2 (ACTN2/3295), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
